J Korean Soc Transplant 2016; 30(1): 44-49
Published online March 31, 2016
https://doi.org/10.4285/jkstn.2016.30.1.44
© The Korean Society for Transplantation
Hyeoncheol Park, M.D.1, Jae Seok Kim, M.D.1, Jee Hyun Kong, M.D.2, Sung Hoon Kim, M.D.3, Sang Wook Park, M.D.1, Shin Han Song, M.D.1, Jae Won Yang, M.D1, Byoung Geun Han, M.D.1 and Seung Ok Choi, M.D.1
Departments of Nephrology1, Oncology2 and Surgery3, Yonsei University Wonju College of Medicine, Wonju, Korea
Correspondence to: Seung Ok Choi
Department of Nephrology, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Korea
Tel: 82-33-741-0509, Fax: 82-33-741-5889
E-mail:kidney77@yonsei.ac.kr
Post-transplant lymphoproliferative disorder (PTLD) is a serious complication resulting in mortality and renal graft failure. PTLD is a heterogeneous disorder, which causes different clinical forms of disease from non-specific viral syndrome to malignant lymphoma and has various etiologies, clinical features, and treatment strategies. Here, we report on a patient who had a PTLD in the hilum of a transplanted kidney at 5 months after renal transplantation. The PTLD resulted in hydronephrosis of the transplanted kidney and graft dysfunction by local urinary tract obstruction. Despite treatment including immunosuppression reduction and rituximab administration, we removed the transplanted kidney from the recipient because the PTLD did not respond to the therapy.
Keywords: Lymphoproliferative disorders, Kidney transplantation, Hydronephrosis